Is Arcellx Inc (ACLX) undervalued? · rev $107.9M
Arcellx Inc (ACLX) is a biotechnology company listed on NASDAQ.
This page asks whether Arcellx Inc (ACLX) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Latest reported ACLX revenue for 2024-12-31 was $107.9M. Net income was -$107.3M. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. ACLX currently screens at market cap $6.73B.
ACLX currently screens at market cap $6.73B. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new ACLX 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare ACLX to the stock page model before you treat a low multiple as a gift.
Not investment advice.